Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics' Focus::CLL

Cancer Genetics has launched Focus::CLL, a next-generation sequencing-based panel for chronic lymphocytic leukemia and small lymphocytic leukemia. The panel assesses seven genes with clinical relevance for prognosis, disease management, and treatment selection. It has an analytical sensitivity of 5 percent. Focus::CLL will be available as an individual test and will also be integrated into the company's Complete offerings for CLL and SLL. In addition, it will be available through Cancer Genetics' Select One clinical trials offering, which provides clinical trial support to biotech and pharmaceutical companies. 

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.